Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 48-53

  Requena, Jesús R ^a   Fu, Min Xin ^a   Ahmed, Mahtab U ^a   Jenkins, Alicia J ^b   Lyons, Timothy J ^b   Thorpe, Suzanne R ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

4 hydroxy nonenal; Lipid peroxidation; Malondialdehyde; Metalcatalysed oxidation; N( ) (carboxymethyl)lysine; Oxidative stress; Protein chemical modification

Indexed keywords

4 HYDROXYNONENAL; BIOLOGICAL MARKER; CARBOHYDRATE; LOW DENSITY LIPOPROTEIN; LYSINE; MALONALDEHYDE; POLYUNSATURATED FATTY ACID; SCHIFF BASE;

ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; GAS CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0030498053     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.48     Document Type: Conference Paper

References (28)

1. Baynes JW. Role of oxidative stress in development of diabetic complications. Diabetes 1991; 40: 405-412
2. Morrow JD, Roberts LJ. Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Rad Biol Med 1991; 10: 195-200
3. Picard S, Parthasarathy S, Fruebis J, Witztum JL. Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptor. Proc Natl Acad Sci USA 1992; 89: 6876-6880
4. Esterbauer H, Gebick J, Puhl H and Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992; 13: 341-390
5. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med 1990; 13: 341-390
6. Loidl-Stahlhofen A, Spiteller G. α-Hydroxyaldehydes, products of lipid peroxidation. Biochim Biophys Acta 1994; 1211: 156-160
7. Mlakar A, Spiteller G. Reinvestigation of lipid peroxidation of linolenic acid. Biochim Biophys Acta 1994; 1214: 209-230
8. Okitani A, Kaneko S, Tashio Y, Hayase F, Kato H. Polymerization of proteins and impairment of their amino acid residues due to vaporized hexanal. Dev Food Sci 1986; 13: 125-134
9. Zyzak DV, Wells-Knecht KJ, Blackledge JA et al. Pathways of the Maillard reaction in vitro and in vivo In: Labuza TP, Reineccius GA, Monnier VM, O'Brien J, Baynes JW, eds. The Maillard Reaction in Chemistry, Food and Health. Royal Society of Chemistry, London, 1994: 274-280
10. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Identification of glyoxal as the dicarbonyl sugar formed on autoxidation of glucose: relevance to pathways of the Maillard reaction in vitro and in vivo Biochemistry 1995; 34: 3702-3709
11. Glomb MA, Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde reactive intermediates of the Maillard reaction. J Biol Chem 1995; 270: 10017-10026
12. Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 1993; 268: 3342-3347
13. Uchida K, Toyokuni S, Nishikawa K et al. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 1994; 33: 12487-12494
14. Esterbauer H, Striegle G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Fr Rad Res Commun 1989; 6: 67-75
15. Richards FM, Wyckoff HW. Bovine pancreatic ribonuclease. In: Boyer PD, ed. The Enzymes, 3rd edn, vol. IV. Academic Press, New York: 647-806.
16. Chio, KS, Tappel, AL. Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malondialdehyde. Biochemistry 1969; 8: 2827-2832
17. Sato Y, Hotta N, Sakamotto N, Matsuoka S, Oshini N, Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochemistry 1979; 21: 104-107
18. Young, IS, Trimble, ER. Measurement of malondialdehyde in plasma by high performance liquid chromatrography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504-508
19. Chio KS, Tappel AL. Synthesis and characterization of the fluorescent products derived from malondialdehyde and amino acids. Biochemsitry 1969; 8: 2821-2826
20. α-acetyl-ε-(2-propenal)lysine as a urinary metabolite of malondialdehyde. J Biol Chem 1985; 260: 15427-15431
21. Estebauer H, Schauer RJ, Zoliner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehye and related aldehydes. Free Rad Biol Med 1991; 11: 81-128
22. Witztum, JL, Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. J Chm Invest 1991; 88: 1785-1792
23. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990; 173: 932-939
24. Klein RL, Laimins M, Lopes-Virella MF. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 1995; 44: 1093-1098
25. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010-1014
26. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 1986; 261: 4889-4894
27. Palinski W, Koschinsky T, Butler SW, Miller E, Vlassara H, Cerami A, Witztum JL. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vasc Biol 1995; 15: 571-582
28. Sell DR, Monnier VM. Structure elucidation of a senescence crosslink from human extracellular matrix: implication of pentoses in the aging process. J Biol Chem 1989; 264: 21597-21602